Clinical and Molecular Hepatology (Dec 2016)

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

  • Byung-Cheol Song

DOI
https://doi.org/10.3350/cmh.2016.0108
Journal volume & issue
Vol. 22, no. 4
pp. 439 – 442

Abstract

Read online

No abstracts available.

Keywords